comparemela.com

Latest Breaking News On - Sanofi regeneron - Page 8 : comparemela.com

Telemedicine expands reach of asthma practices

SAN ANTONIO — Providers can use telemedicine to engage patients with asthma who face obstacles in access to care remotely, according to data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.“You can use a telemedicine encounter as a way to increase your presence at your hospital or to help a rural hospital,” Allison C. Ramsey, MD, FACAAI,

San-antonio
Texas
United-states
Arkansas
American
Byrichard-gawel
Sanofi-regeneron
Allisonc-ramsey
Kristen-dowd
University-of-rochester
American-academy-of-allergy
Rochester-city-school-district

Alirocumab improves coronary plaque burden in asymptomatic patients with FH

PCSK9 inhibition with alirocumab, on top of high-intensity statin therapy, resulted in significant coronary plaque regression among patients with familial hypercholesterolemia and no clinical atherosclerotic CVD, researchers reported.The results of the phase 4, open-label, multicenter, single-arm ARCHITECT study were published in Circulation.

Madrid
Spain
Sanofi-regeneron
Amgen
Clinico-san-carlos-university-hospital

Evolving Treatment Landscape of EoE: Applying the Latest Evidence to Optimize Care

Evolving Treatment Landscape of EoE: Applying the Latest Evidence to Optimize Care
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

United-states
California
Chicago
Illinois
San-diego
Americans
Seemas-aceves
Bristol-meyers-squibb
Sanofi-regeneron
Seema-aceves
Ellodi-adare
Bristol-meyers-squibb-receptos

Telemedicine saves time, money in penicillin allergy de-labeling

SAN ANTONIO — Providers can use telemedicine to conduct penicillin and other drug allergy screenings, saving time and costs, according to data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.“Telemedicine is a way for us to spread our tentacles a little bit and improve our reach,” Allison C. Ramsey, MD, FACAAI, FAAAAI, clinical assistant

United-states
San-antonio
Texas
American
Byrichard-gawel
Kristen-dowd
Sanofi-regeneron
Allisonc-ramsey
Rochester-regional-health
University-of-rochester
American-academy-of-allergy
American-academy

Benefits outweigh risks when switching biologics for rheumatoid arthritis

Patients with rheumatoid arthritis who achieve only a partial response with adalimumab demonstrate a low risk for worsened symptoms and a high likelihood of meaningful improvement when switching to sarilumab, according to data.

Jeffrey-curtis
Sanofi-regeneron
University-of-alabama-at-birmingham
Disease-activity-score

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.